检索范围:
排序: 展示方式:
Prevalence of asthma symptoms in Golestan schoolchildren aged 6–7 and 13–14 years in Northeast Iran
null
《医学前沿(英文)》 2016年 第10卷 第3期 页码 345-350 doi: 10.1007/s11684-016-0462-y
Asthma is the most common chronic disease among children, and its incidences are often imminent among elementary schoolchildren. This study aimed to examine the prevalence of asthma symptoms in Golestan schoolchildren aged 6–7 and 13–14 years in Northeast Iran. The prevalence rate was compared according to age group (aged 6–7 years vs. aged 13–14 years) and gender (male vs. female). In this cross-sectional study, 1706 Iranian schoolchildren aged 6–7 and 13–14 years in Golestan Province were enrolled. Participants completed questionnaires between February and July 2014. Asthma symptoms were assessed using the questionnaire of the International Study of Asthma and Allergies in Childhood protocol in Persian. The logistic regression model was used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) of the asthma symptoms for each of the gender and age groups. The prevalence rates of “current asthma” symptoms and “asthma ever” in all the children were estimated as 9.5% and 7.5%, respectively. The prevalence of asthma (“asthma ever” and “wheezing in the past 12 months”) in junior high schoolchildren (aged 13–14 years) is higher than that in elementary schoolchildren (aged 6–7 years) (P <0.05). The prevalence of the severity of wheezing in girls is lower than that in boys (OR= 1.7, 95%CI= 1.06–2.96, P = 0.02). Asthma is still a major public health problem. This study shows that the prevalence of the asthma symptoms in boys is lower than that in girls in both age groups, and the severity of asthma in girls is higher than that in boys aged 13–14 years.
关键词: asthma asthma symptoms epidemiology childhood chronic disease
《医学前沿(英文)》 2022年 第16卷 第4期 页码 574-583 doi: 10.1007/s11684-021-0882-1
Not asthma, but GERD: case report
WANG Zhonggao
《医学前沿(英文)》 2007年 第1卷 第1期 页码 115-119 doi: 10.1007/s11684-007-0022-6
关键词: resistance mechanism responsible unappreciated responsiveness different
null
《医学前沿(英文)》 2018年 第12卷 第3期 页码 340-349 doi: 10.1007/s11684-017-0565-0
Benralizumab is a monoclonal antibody that targets interleukin-5 receptor α to deplete blood eosinophils and improve the clinical outcomes of allergic asthma. We conducted a meta-analysis to evaluate the safety and efficacy of different doses of benralizumab in patients with eosinophilic asthma. All randomized controlled trials involving benralizumab treatment for patients with eosinophilic asthma, which were searched in PubMed, Embase, and the Cochrane Library published until January 2017, as well as the rate of asthmatic exacerbation, pulmonary functionality, asthma control, quality of life scores, and adverse events were included. Randomized-effect models were used in the meta-analysis to calculate the pooled mean difference, relative risks, and 95% confidence intervals. Five studies involving 1951 patients were identified. Compared with the placebo, benralizumab treatment demonstrated significant improvements in the forced expiratory volume in 1?s (FEV1), Asthma Quality of Life Questionnaire scores, decreased asthmatic exacerbation and Asthma Control Questionnaire-6 (ACQ-6) scores. Benralizumab treatment was also not associated with increased adverse events. These findings indicated that benralizumab can be safely used to improve FEV1, enhance patient symptom control and quality of life, and reduce the risk of exacerbations and ACQ-6 scores in patients with eosinophilic asthma. Furthermore, our meta-analysis showed that benralizumab with 30 mg (every eight weeks) dosage can improve the health-related quality of life and appear to be more effective than 30 mg (every four weeks) dosage. Overall, data indicated that the optimal dosing regimen for benralizumab was possibly 30 mg (every eight weeks).
关键词: benralizumab anti-interleukin-5 monoclonal antibody eosinophilic asthma meta-analysis
《医学前沿(英文)》 2022年 第16卷 第6期 页码 919-931 doi: 10.1007/s11684-021-0918-6
关键词: preeclampsia recombinant protein diannexin microparticle NLRP3 inflammasome phosphatidylserin
A belated revelation: from gastroesophageal reflux derived asthma to laryngotracheal irritation even
WANG Zhonggao
《医学前沿(英文)》 2008年 第2卷 第2期 页码 127-129 doi: 10.1007/s11684-008-0023-0
关键词: laryngotracheal irritation/spasm gastro-oesophago-laryngo-tracheal sequence fundaplication encouraging
Cerebral regional and network characteristics in asthma patients: a resting-state fMRI study
Siyi Li, Peilin Lv, Min He, Wenjing Zhang, Jieke Liu, Yao Gong, Ting Wang, Qiyong Gong, Yulin Ji, Su Lui
《医学前沿(英文)》 2020年 第14卷 第6期 页码 792-801 doi: 10.1007/s11684-020-0745-1
关键词: asthma brain regional activation functional connectivity resting-state fMRI
Outcome of Stretta radiofrequency and fundoplication for GERD-related severe asthmatic symptoms
null
《医学前沿(英文)》 2015年 第9卷 第4期 页码 437-443 doi: 10.1007/s11684-015-0422-y
This study aimed to investigate the outcome of treatment with Stretta radiofrequency (SRF) or laparoscopic Nissen fundoplication (LNF). A total of 137 gastroesophageal reflux disease (GERD) patients with severe asthmatic symptoms who responded inadequately to medical treatment for asthma were investigated. The patients were followed up 1 year and 5 years after SRF (n = 82) or LNF (n = 55) treatment. A questionnaire covering 29 related symptoms and medication use was employed. Digestive, respiratory, and ear-nose-throat (ENT) symptom scores significantly decreased after antireflux treatment. Symptom scores respectively changed from 17.2±10.1, 31.9±6.6, and 21.1±11.8 to 5.0±6.2, 11.5±10.2, and 6.3±6.8 at 1 year and to 5.6±6.5, 13.1±10.1, and 7.8±7.2 at 5 years (P <0.001). The outcome of LNF was significantly better than that of SRF in terms of digestive (P <0.001, P = 0.001), respiratory (P = 0.006, P = 0.001), and ENT symptoms (P = 0.006, P = 0.003) at both 1 year and 5 years. SRF and LNF were both effective against the digestive symptoms of GERD as well as GERD-related severe asthmatic and ENT symptoms, with better outcomes exhibited by the LNF group. Severe asthmatic symptoms and GERD were closely associated, and this finding warrants further study.
关键词: asthma gastroesophageal reflux Stretta radiofrequency laparoscopic Nissen fundoplication
肝硬化患者胃黏膜微生物菌群特征及其与胃肠道症状的相关性分析 Article
陈燕飞, 郭静, 陈春雷, 石鼎, 方戴琼, 季峰, 李兰娟
《工程(英文)》 2021年 第7卷 第4期 页码 507-514 doi: 10.1016/j.eng.2020.04.014
研究表明,肝硬化患者的口腔和肠道微生物群与健康人群存在差异。胃位于口腔和肠道之间,关于其黏膜微生物群结构所知甚少。本研究采用16S rRNA焦磷酸测序技术分析了肝硬化患者和对照组的胃黏膜微生物群。研究发现,组织学和测序法均证实肝硬化患者幽门螺杆菌感染率显著降低。在幽门螺杆菌阴性人群中,可以按细菌组成结构将胃黏膜微生物群分为4个聚类,其中聚类1和2主要是肝硬化患者,聚类3主要是健康人群,而聚类4中肝硬化患者和健康人群各占一半左右。这些不同聚类间的成分和功能存在显著差异。在属的水平上,聚类1和2分别富集奈瑟菌和链球菌。在功能基因分类上,相对而言,聚类2缺乏涉及遗传信息处理以及与聚糖生物合成和代谢相关的功能基因。胃黏膜菌群结构表现为聚类2的患者胃肠道症状更严重,既往内镜下曲张静脉的治疗率显著高于其他组。我们的研究结果表明,在肝硬化中,幽门螺杆菌和非幽门螺杆菌的定植都受到影响。虽然幽门螺杆菌阴性的胃黏膜微生物结构表现出相当大的异质性,但特定的胃微生物群与临床特征之间仍然存在相关性。既往内镜下静脉曲张治疗会引起胃黏膜菌群结构明显改变,从而加重幽门螺杆菌阴性肝硬化患者的胃肠道症状。
A giant Müllerian duct cyst in the perineum: a case report
null
《医学前沿(英文)》 2012年 第6卷 第4期 页码 440-443 doi: 10.1007/s11684-012-0222-6
The authors present a case report of a giant Müllerian duct cyst in the perineum. A 37-year-old man presented with a mass with the size of 50 cm×40 cm×30 cm in the perineum. Computed tomography (CT) scan and magnetic resonance imaging (MRI) of the pelvis and perineum found a huge multilocular cystic mass. X-ray film of the pelvis showed a giant soft-tissue shadow of high density in the perineum. Voiding cystourethrogram did not show any cyst interlinked to posterior urethra. After related examinations, the patient underwent open surgical resection of the cyst. Pathologic examination confirmed the presence of a Müllerian duct cyst. Huge Müllerian duct cyst is uncommon in clinic. Treatments of Müllerian duct cysts depend on their sizes and symptoms.
Won-Mo Jung, In-Soo Park, Ye-Seul Lee, Chang-Eop Kim, Hyangsook Lee, Dae-Hyun Hahm, Hi-Joon Park, Bo-Hyoung Jang, Younbyoung Chae
《医学前沿(英文)》 2019年 第13卷 第1期 页码 112-120 doi: 10.1007/s11684-017-0582-z
关键词: acupuncture indication neural network pattern identification prediction
Tim-3 mRNA expression in peripheral blood lymphocytes from asthmatic patients
Xiaoxia LU, Weikun HU, Shengdao XIONG, Guopeng XU, Fen LAN
《医学前沿(英文)》 2009年 第3卷 第2期 页码 187-190 doi: 10.1007/s11684-009-0033-6
关键词: asthma airway inflammation peripheral blood lymphocyte Tim-3
Insult of gastroesophageal reflux on airway: clinical significance of pharyngeal nozzle
null
《医学前沿(英文)》 2015年 第9卷 第1期 页码 117-122 doi: 10.1007/s11684-014-0343-1
At the very time of global paying the highest attention to the worst insults of smoking as well as haze on the airway, everybody knows both are exogenous and noticeable. However, people mostly, including many medical personnel, do not know how badly the gastroesophageal reflux (GER) insults on our own airway. Symptoms of GER are commonly seen as heartburn and regurgitation, which can be mostly tolerated. However, when the up going gastric content reversely passes the esophagus and then the distal pharynx, where it appears a beak like stricture, serving as a nozzle, so as to produce numerous micro-particles and reach the oro-nasal cavity and also the airway causing allergic rhinitis and asthmatic attacks, even pulmonary parenchyma lesions. It will reduce life quality or even jeopardize life. The point that the endogenous insult appears in the respiratory system, but originates from the digestive tract is not well known and often undiagnosed and not correctly treated. The GER induced airway challenge is a treatable and preventive entity, as soon as a diagnosis is made, a good relief could be expected by means of life style adjustment, medicine, or fixation of the patulous cardia through radiofrequency or fundoplication. The author Dr. Zhonggao Wang had suffered it for long and symptoms disappeared for 8 years after anti-reflux surgery. Here is a presentation of Dr. Zhonggao Wang and his team’s work and would call attention to the public so as to recognize this relatively unknown entity — a treatable condition occurring from human itself, but not from outside surroundings as smoking or haze does.
关键词: gastroesophageal reflux airway pharyngeal nozzle micro-aspiration asthma
Mengxue Huang, Jingjing Wang, Runshun Zhang, Zhuying Ni, Xiaoying Liu, Wenwen Liu, Weilian Kong, Yao Chen, Tiantian Huang, Guihua Li, Dan Wei, Jianzhong Liu, Xuezhong Zhou
《医学前沿(英文)》 2020年 第14卷 第3期 页码 357-367 doi: 10.1007/s11684-019-0699-3
关键词: pediatric cough complex network symptoms traditional Chinese medicine electronic medical records
起病时无呼吸道症状或发热的重型或危重型COVID-19患者的临床特征及转归 Article
许娟娟, 殷峥嵘, 刘宇, 汪速飞, 段丽敏, 安義, 范金烁, 廖婷婷, 金阳, 陈建国
《工程(英文)》 2021年 第7卷 第10期 页码 1454-1460 doi: 10.1016/j.eng.2020.09.009
以不典型症状起病的新型冠状病毒肺炎(COVID-19)患者在早期容易漏诊,部分患者可发展为重症甚至危重症,目前尚缺乏相关的临床研究。本研究回顾了在起病时无典型症状(呼吸道症状或发热)的重型或危重型COVID-19患者的临床、实验室和影像学特征及治疗情况,并随访至患者死亡或治愈出院。2020年1月25日至2020年2月10日期间,武汉协和医院西院共收治943例COVID-19患者,其中909例(96.4%)重型或危重型COVID-19患者中有10例(1.1%)患者在起病时无呼吸系统症状或发热。10例患者的中位年龄为63岁[四分位区间(IQR):57~72],其中7例为男性。从出现症状到入院的中位时间为14 d(IQR:7~20)。10例患者中有8例患有慢性基础疾病。入院时,5例患者有乏力症状(n = 5)、4例有头痛或头晕(n = 4)、5例有腹泻(n = 5)、3例有厌食(n = 3)、3例有恶心或呕吐(n = 3)以及1例患者有眼部不适症状(n = 1)。4例患者外周血淋巴细胞减少。影像学检查显示9例患者有双侧肺炎,1例有单侧肺炎。最终2例患者死亡,8例患者治愈出院。8例患者从入院到出院的中位时间为24 d(IQR:13~43)。总的来说,部分重型或危重型COVID-19 患者在起病时无呼吸道症状或发热,此类不典型患者应尽早发现和隔离,否则可能延误病情,导致住院时间延长,甚至死亡。因此,对COVID-19患者密切接触者,即使无呼吸道症状或发热,也应及时进行核酸检测或胸部CT扫描以筛查不典型症状患者。
标题 作者 时间 类型 操作
Prevalence of asthma symptoms in Golestan schoolchildren aged 6–7 and 13–14 years in Northeast Iran
null
期刊论文
Lung function and air pollution exposure in adults with asthma in Beijing: a 2-year longitudinal panel
期刊论文
Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized
null
期刊论文
Recombinant protein diannexin prevents preeclampsia-like symptoms in a pregnant mouse model via reducing
期刊论文
A belated revelation: from gastroesophageal reflux derived asthma to laryngotracheal irritation even
WANG Zhonggao
期刊论文
Cerebral regional and network characteristics in asthma patients: a resting-state fMRI study
Siyi Li, Peilin Lv, Min He, Wenjing Zhang, Jieke Liu, Yao Gong, Ting Wang, Qiyong Gong, Yulin Ji, Su Lui
期刊论文
Outcome of Stretta radiofrequency and fundoplication for GERD-related severe asthmatic symptoms
null
期刊论文
Characterization of hidden rules linking symptoms and selection of acupoint using an artificial neural
Won-Mo Jung, In-Soo Park, Ye-Seul Lee, Chang-Eop Kim, Hyangsook Lee, Dae-Hyun Hahm, Hi-Joon Park, Bo-Hyoung Jang, Younbyoung Chae
期刊论文
Tim-3 mRNA expression in peripheral blood lymphocytes from asthmatic patients
Xiaoxia LU, Weikun HU, Shengdao XIONG, Guopeng XU, Fen LAN
期刊论文
Symptom network topological features predict the effectiveness of herbal treatment for pediatric cough
Mengxue Huang, Jingjing Wang, Runshun Zhang, Zhuying Ni, Xiaoying Liu, Wenwen Liu, Weilian Kong, Yao Chen, Tiantian Huang, Guihua Li, Dan Wei, Jianzhong Liu, Xuezhong Zhou
期刊论文